• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

2 years ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Injective Seeks SEC Approval to Become a Transfer Agent

chest

Injective has filed Form TA1 with the SEC to register as a transfer agent, aiming to support regulated real-world asset infrastructure on-chain.

user avatarElias Mukuru

The Critical Role of Transfer Agents in Financial Markets

chest

Transfer agents are crucial for maintaining securities ownership records and facilitating transfers, especially as markets transition to on-chain solutions.

user avatarDiego Alvarez

dYdX Chains v51 Upgrade Enhances Market Flexibility with Smart Contracts

chest

The v51 upgrade of dYdX Chains allows users to launch perpetual markets without governance intervention, enhancing market flexibility.

user avatarKenji Takahashi

Sui's Confidential Transactions Aim for Selective Confidentiality

chest

Sui is exploring a selective confidentiality model for its confidential transactions, allowing sender and recipient addresses to remain visible while hiding amounts and balances, addressing privacy concerns for businesses.

user avatarMaria Fernandez

Uniswap Governance Proposes Fee Routing for UNI Token Burns

chest

Uniswap governance is reviewing a proposal to route protocol fees from selected Optimism pools toward UNI token burns, aiming to strengthen the connection between trading activity and token economics.

user avatarGustavo Mendoza

Account Abstraction Set to Transform Crypto User Experience

chest

The introduction of account abstraction aims to address user experience issues in the crypto space, such as intimidating seed phrases and confusing gas fees, with a broader rollout planned for September 2026.

user avatarRajesh Kumar

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.